AR025455A1 - Mesoprogestinas (moduladores de receptores de progesterona) como componentes de anticonceptivos femeninos - Google Patents
Mesoprogestinas (moduladores de receptores de progesterona) como componentes de anticonceptivos femeninosInfo
- Publication number
- AR025455A1 AR025455A1 ARP000104536A ARP000104536A AR025455A1 AR 025455 A1 AR025455 A1 AR 025455A1 AR P000104536 A ARP000104536 A AR P000104536A AR P000104536 A ARP000104536 A AR P000104536A AR 025455 A1 AR025455 A1 AR 025455A1
- Authority
- AR
- Argentina
- Prior art keywords
- contraception
- mesoprogestines
- conceptives
- components
- female
- Prior art date
Links
- 102000003998 progesterone receptors Human genes 0.000 title abstract 2
- 108090000468 progesterone receptors Proteins 0.000 title abstract 2
- 230000001270 agonistic effect Effects 0.000 abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 2
- 102000005962 receptors Human genes 0.000 abstract 2
- 108020003175 receptors Proteins 0.000 abstract 2
- 230000003042 antagnostic effect Effects 0.000 abstract 1
- 230000000708 anti-progestin effect Effects 0.000 abstract 1
- 239000003418 antiprogestin Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000000262 estrogen Substances 0.000 abstract 1
- 229940011871 estrogen Drugs 0.000 abstract 1
- 229940124566 female contraceptive agent Drugs 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229940127557 pharmaceutical product Drugs 0.000 abstract 1
- 239000000583 progesterone congener Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Uso de mesoprogestinas para producir un producto farmacéutico para la anticoncepcion femenina, a una preparacion farmacéutica para la anticoncepcionfemenina y a un método anticonceptivo femenino que administra cantidades efectivas de unamesoprogesti na en una mujer que desea contar con anticoncepcion.Opcionalmente, la mesoprogestina puede utilizarse en combinacion con un estrogeno. Las mesoprogestinas se definen como compuestos que disponen de actividadtanto agonística comoantagonística en el r eceptor de progesterona (RP) in vivo. Estabilizan la funcion de RP en un nivel intermedio entre agonístico yantagonístico. Con las progestinas o las antiprogestinas no es posible lograr estados funcionales correspondientes.J867, J912, J956 y J1042 s on lasmesoprogestinas preferibles de acuerdo con la presente.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38613399A | 1999-08-31 | 1999-08-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR025455A1 true AR025455A1 (es) | 2002-11-27 |
Family
ID=23524305
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP000104536A AR025455A1 (es) | 1999-08-31 | 2000-08-31 | Mesoprogestinas (moduladores de receptores de progesterona) como componentes de anticonceptivos femeninos |
Country Status (28)
| Country | Link |
|---|---|
| EP (1) | EP1605949A2 (es) |
| JP (1) | JP2003511399A (es) |
| KR (1) | KR20020038745A (es) |
| CN (1) | CN1384748A (es) |
| AR (1) | AR025455A1 (es) |
| AU (1) | AU781835B2 (es) |
| BG (1) | BG106441A (es) |
| BR (1) | BR0013711A (es) |
| CA (1) | CA2383650A1 (es) |
| CO (1) | CO5190694A1 (es) |
| CZ (1) | CZ2002707A3 (es) |
| EA (1) | EA006805B1 (es) |
| EE (1) | EE200200103A (es) |
| HR (1) | HRP20020265A2 (es) |
| HU (1) | HUP0202515A3 (es) |
| IL (1) | IL148415A0 (es) |
| LT (1) | LT5001B (es) |
| LV (1) | LV12940B (es) |
| MX (1) | MXPA02002186A (es) |
| NO (1) | NO20020998L (es) |
| NZ (1) | NZ517470A (es) |
| PE (1) | PE20010579A1 (es) |
| PL (1) | PL353994A1 (es) |
| SI (1) | SI20853A (es) |
| SK (1) | SK2982002A3 (es) |
| UA (1) | UA77150C2 (es) |
| WO (1) | WO2001026603A2 (es) |
| YU (1) | YU13902A (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005539016A (ja) * | 2002-08-02 | 2005-12-22 | シエーリング アクチエンゲゼルシャフト | 女性用受胎調節及びホルモン置換療法のための高められた抗ゴナドトロピン活性を有するプロゲステロン受容体モジュレーター |
| DE10236405A1 (de) | 2002-08-02 | 2004-02-19 | Schering Ag | Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie |
| US7772219B2 (en) * | 2003-05-02 | 2010-08-10 | Teva Women's Health, Inc. | Methods of hormonal treatment utilizing extended cycle contraceptive regimens |
| US20050215535A1 (en) * | 2004-03-24 | 2005-09-29 | Kristof Chwalisz | Sequential SPRM/progestin treatment |
| JP5288796B2 (ja) * | 2004-07-07 | 2013-09-11 | ワイス・エルエルシー | 周期的プロゲスチンレジメン及びキット |
| DE102005050729A1 (de) * | 2005-10-19 | 2007-04-26 | Schering Ag | Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption |
| US9616073B2 (en) | 2009-04-14 | 2017-04-11 | Laboratoire Hra-Pharma | Method for on-demand contraception |
| CN110548034A (zh) * | 2019-07-12 | 2019-12-10 | 广州莎蔓生物科技有限公司 | 一种怀孕阻断药物 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2054271A (en) | 1932-05-17 | 1936-09-15 | Schering Kahlbaum Ag | Production of crystallized hormone esters |
| DE699310C (de) | 1936-11-20 | 1940-11-27 | Chemische Ind Ges | Verfahren zur Herstellung von in 3-Stellung veresterten Verbindungen vom Typus des Oestradiols |
| US2225419A (en) | 1937-03-01 | 1940-12-17 | Schering Corp | Process for the conversion of 17-cisalcohols of the cyclopentanopolyhydrophenanthrene series into the corresponding 17-trans-alcohols |
| US2611773A (en) | 1951-08-21 | 1952-09-23 | Upjohn Co | Estradiol 17-cyclopenetanepropionate |
| US2990414A (en) | 1957-03-26 | 1961-06-27 | Syntex Sa | 17-undecenoate of estradiol |
| DE3337450A1 (de) | 1983-10-12 | 1985-04-25 | Schering AG, 1000 Berlin und 4709 Bergkamen | Prostaglandine und antigestagene fuer den schwangerschaftsabbruch |
| FI101601B1 (fi) * | 1987-09-24 | 1998-07-31 | Jencap Research Ltd | Ehkäisyvalmiste sekä estrogeenin ja progestiinin käyttö ehkäisyvalmisteen valmistusmenetelmässä |
| US5439913A (en) | 1992-05-12 | 1995-08-08 | Schering Aktiengesellschaft | Contraception method using competitive progesterone antagonists and novel compounds useful therein |
| US5516769A (en) | 1993-02-19 | 1996-05-14 | The Medical College Of Hampton Roads | Method of inhibiting fertilization |
| DE4332283A1 (de) | 1993-09-20 | 1995-04-13 | Jenapharm Gmbh | Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| DE4332284C2 (de) * | 1993-09-20 | 1997-05-28 | Jenapharm Gmbh | 11-Benzaldoxim-17beta-methoxy-17alpha-methoxymethyl-estradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| DE4429397C2 (de) | 1994-08-09 | 2003-11-20 | Jenapharm Gmbh | Estra-1,3,5(10)-trien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen |
| DE4429398C2 (de) | 1994-08-09 | 1997-09-11 | Jenapharm Gmbh | Verwendung von Estra-1,3,5(10)-trien-Derivaten zur hormonalen Kontrazeption |
| NZ295365A (en) * | 1994-10-24 | 1999-07-29 | Schering Ag | Competitive progesterone antagonists for regulating female fertility as required |
| US6040340A (en) * | 1996-05-07 | 2000-03-21 | Schering Aktiengesellschaft | Implantation rates after in vitro fertilization, treatment of infertility and early pregnancy loss with a nitric oxide donor alone or in combination with progesterone, and a method for contraception with nitric oxide inhibitors |
| ATE213947T1 (de) * | 1996-06-25 | 2002-03-15 | Akzo Nobel Nv | Progestogen-anti-progestogen therapien |
| WO1998005679A2 (en) * | 1996-08-05 | 1998-02-12 | Duke University | Mixed agonists of the progesterone receptor and assays therefor |
| DE19809845A1 (de) * | 1998-03-03 | 1999-09-09 | Jenapharm Gmbh | S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen |
| CN1353717A (zh) * | 1999-05-04 | 2002-06-12 | 莱加制药公司 | 四环黄体酮受体调节剂化合物及其方法 |
-
2000
- 2000-08-31 SI SI200020043A patent/SI20853A/sl not_active IP Right Cessation
- 2000-08-31 IL IL14841500A patent/IL148415A0/xx unknown
- 2000-08-31 AR ARP000104536A patent/AR025455A1/es unknown
- 2000-08-31 UA UA2002032429A patent/UA77150C2/uk unknown
- 2000-08-31 KR KR1020027002785A patent/KR20020038745A/ko not_active Ceased
- 2000-08-31 PE PE2000000894A patent/PE20010579A1/es not_active Application Discontinuation
- 2000-08-31 JP JP2001529395A patent/JP2003511399A/ja active Pending
- 2000-08-31 BR BR0013711-1A patent/BR0013711A/pt not_active IP Right Cessation
- 2000-08-31 WO PCT/IB2000/002053 patent/WO2001026603A2/en not_active Ceased
- 2000-08-31 CA CA002383650A patent/CA2383650A1/en not_active Abandoned
- 2000-08-31 EE EEP200200103A patent/EE200200103A/xx unknown
- 2000-08-31 YU YU13902A patent/YU13902A/sh unknown
- 2000-08-31 MX MXPA02002186A patent/MXPA02002186A/es not_active Application Discontinuation
- 2000-08-31 HU HU0202515A patent/HUP0202515A3/hu unknown
- 2000-08-31 CO CO00065517A patent/CO5190694A1/es not_active Application Discontinuation
- 2000-08-31 CN CN00812308A patent/CN1384748A/zh active Pending
- 2000-08-31 NZ NZ517470A patent/NZ517470A/en unknown
- 2000-08-31 CZ CZ2002707A patent/CZ2002707A3/cs unknown
- 2000-08-31 PL PL00353994A patent/PL353994A1/xx not_active Application Discontinuation
- 2000-08-31 EA EA200200284A patent/EA006805B1/ru not_active IP Right Cessation
- 2000-08-31 EP EP00991299A patent/EP1605949A2/en not_active Withdrawn
- 2000-08-31 SK SK298-2002A patent/SK2982002A3/sk unknown
- 2000-08-31 HR HR20020265A patent/HRP20020265A2/hr not_active Application Discontinuation
- 2000-08-31 AU AU32150/01A patent/AU781835B2/en not_active Ceased
-
2002
- 2002-02-26 BG BG06441A patent/BG106441A/bg unknown
- 2002-02-28 NO NO20020998A patent/NO20020998L/no not_active Application Discontinuation
- 2002-03-26 LT LT2002035A patent/LT5001B/lt not_active IP Right Cessation
- 2002-03-28 LV LVP-02-52A patent/LV12940B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BG106441A (bg) | 2002-09-30 |
| KR20020038745A (ko) | 2002-05-23 |
| LT5001B (lt) | 2003-03-25 |
| JP2003511399A (ja) | 2003-03-25 |
| MXPA02002186A (es) | 2002-09-02 |
| IL148415A0 (en) | 2002-09-12 |
| EP1605949A2 (en) | 2005-12-21 |
| AU781835B2 (en) | 2005-06-16 |
| SK2982002A3 (en) | 2002-07-02 |
| LT2002035A (lt) | 2002-10-25 |
| WO2001026603A3 (en) | 2002-01-17 |
| EE200200103A (et) | 2003-04-15 |
| YU13902A (sh) | 2006-01-16 |
| NO20020998L (no) | 2002-03-14 |
| EA200200284A1 (ru) | 2002-10-31 |
| EA006805B1 (ru) | 2006-04-28 |
| CZ2002707A3 (cs) | 2002-11-13 |
| PL353994A1 (en) | 2003-12-15 |
| WO2001026603A2 (en) | 2001-04-19 |
| NZ517470A (en) | 2004-03-26 |
| HRP20020265A2 (en) | 2004-02-29 |
| HUP0202515A3 (en) | 2004-06-28 |
| AU3215001A (en) | 2001-04-23 |
| UA77150C2 (en) | 2006-11-15 |
| HUP0202515A2 (hu) | 2002-12-28 |
| NO20020998D0 (no) | 2002-02-28 |
| CO5190694A1 (es) | 2002-08-29 |
| PE20010579A1 (es) | 2001-06-04 |
| SI20853A (sl) | 2002-10-31 |
| LV12940B (en) | 2003-06-20 |
| CN1384748A (zh) | 2002-12-11 |
| CA2383650A1 (en) | 2001-04-19 |
| BR0013711A (pt) | 2002-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2256365A1 (en) | Compositions, methods and devices for the transdermal delivery of drugs | |
| PT836506E (pt) | Penso transdermico para administracao de 17-desacetil norgestimato so ou em combinacao com um estrogenio | |
| PT87053A (pt) | Processo para a preparacao de composicoes contraceptivas contendo meletonina e metodo para efectuar a contracepcao | |
| PE20051038A1 (es) | Uso extendido de combinacion que comprende estrogenos y progestinas | |
| EP1260206A3 (en) | Pants-type disposable wearing article | |
| RU2005140277A (ru) | Система доставки лекарственного вещества | |
| DK1272504T3 (da) | 8.Beta-hydrocarbylsubstituerede östradiener til anvendelse som selektive östrogener | |
| AR035904A1 (es) | 5-[2-hidroxi-3-1-(3-trifluorometilfenil)-ciclopropil-propionilamino]-ftalida y compuestos relacionados con actividad moduladora del receptor de progesterona | |
| TW200607798A (en) | Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof | |
| ES2162900T3 (es) | Composicion liquida de l-n-mentol y procedimiento para su preparacion. | |
| EA200900451A1 (ru) | Способ получения композиции эстрадиола с медленным высвобождением ( варианты ), микросферы эстрадиола и холестерина и способ для одновременной контрацепции и гормонозамещения | |
| AR025455A1 (es) | Mesoprogestinas (moduladores de receptores de progesterona) como componentes de anticonceptivos femeninos | |
| EA200100108A1 (ru) | Применение биогенных сульфаматов эстрогенов для гормонзаместительной терапии | |
| WO2006053172A3 (en) | The use of estriol and other estranes, estrogens and estrogen receptor active compositions in the treatment of psoriasis and other autoimmune diseases | |
| BR0214634A (pt) | Sistemas terapêuticos transdérmicos contendo hormÈnio esteróide e contendo monocaprilato de propilenoglicol | |
| EP1890758B1 (en) | Dosage form cap for an applicator | |
| CR10289A (es) | "estratrienos 9-alfa-sustituidos como estrogenos de eficacia selectiva"(divisional) | |
| AR033160A1 (es) | Producto absorbente | |
| PE20060318A1 (es) | Forma de administracion para la contracepcion hormonal | |
| AR025457A1 (es) | Mesoprogestinas (moduladores de receptores de progesterona) para el tratamiento y la prevencion de trastornos ginecologicos benignos hormona-dependientes | |
| AR025456A1 (es) | Mesoprogestinas (moduladores de receptor de progesterona) como componentes de composiciones utilizadas para la terapia de sustitucion hormonal (trh) | |
| DE10250470A1 (de) | Körperhygieneartikel aus saugfähigem Material - Urin-Rest-Absorber (URA) für Männer | |
| KR970005295A (ko) | 죽염과 운모를 유효성분으로 함유하는 질정제 | |
| ATE546144T1 (de) | Verwendung von estradiolvalerat in kombination mit dienogest zur oralen therapie der dysf unktionellen uterinen blutung in einheit mit einer oralen kontrazeption | |
| Hurst | Dunedin research on IUDs |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |